Comparison of A-PRF vs Bone Wax in Hemostasis, Pain Relief and Healing Following Exodontia

NCT ID: NCT05744726

Last Updated: 2023-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

129 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare the pain relief and healing effect of A-PRF and Bone-wax in patients having mandibular tooth-extractions. The main question\[s\] it aims to answer are:

In the perspective of improvement in pain and healing;

* Does A-PRF performs better than control group?
* Does Bone-wax performs better than control group?
* Healing index and Pain scale score Comparison of A-PRF and Bone-wax; if one is better than the other? Participants will be asked to give resoponse to a post-operative symptom severiety (PoSSe) scale. An investigator will score the patient's extraction for hemostasis and on healing index \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Extraction Socket Hemostasis Post-Extraction Socket Pain Relief Post-Extraction Socket Healing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A-PRF

Advance Platelet-Rich Fibrin

Group Type EXPERIMENTAL

A-PRF

Intervention Type BIOLOGICAL

0.5 to 1g of Advance Platelet-Rich Fibrin (A-PRF) clot for each dental socket.

Bone-wax

Group Type ACTIVE_COMPARATOR

Bone-wax

Intervention Type COMBINATION_PRODUCT

0.5 to 1g of Bone-wax for each dental socket

Conventional Dental Extraction protocol

Control Group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A-PRF

0.5 to 1g of Advance Platelet-Rich Fibrin (A-PRF) clot for each dental socket.

Intervention Type BIOLOGICAL

Bone-wax

0.5 to 1g of Bone-wax for each dental socket

Intervention Type COMBINATION_PRODUCT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

combination of beeswax and other products

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who need extraction of mandibular posterior teeth
* Overall, systemically healthy individuals (Established based on history, i.e., patients who do not take medicine for any systemic condition).
* INR within normal range.

Exclusion Criteria

* Patients with a diagnosed systemic condition.
* Patients who are immunocompromised.
* Patients who are unwilling to participate or withdraw from the study.
* Patients who fail to report on the seventh and twenty-first post-extraction day.
* Patients with physical or mental impairments who need assistance in taking their medications.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jinnah Postgraduate Medical Centre

OTHER_GOV

Sponsor Role collaborator

Altamash Institute of Dental Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rehan Ahmad

Demonstrator/Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jinnah Postgraduate Medical Centre

Karachi, Sindh, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rehan Ahmad, BDS

Role: primary

+92 343 8850508

Jehan Alam, FCPS

Role: backup

+92 300 2811979

References

Explore related publications, articles, or registry entries linked to this study.

Ruta DA, Bissias E, Ogston S, Ogden GR. Assessing health outcomes after extraction of third molars: the postoperative symptom severity (PoSSe) scale. Br J Oral Maxillofac Surg. 2000 Oct;38(5):480-7. doi: 10.1054/bjom.2000.0339.

Reference Type BACKGROUND
PMID: 11010778 (View on PubMed)

Landry RG, Turnbell RS, Howley T (1988) Effectiveness of benzydamine HCL in treatment of periodontal post-surgical patients. Res Clin Forums 10:105-118.

Reference Type BACKGROUND

Yelamali T, Saikrishna D. Role of platelet rich fibrin and platelet rich plasma in wound healing of extracted third molar sockets: a comparative study. J Maxillofac Oral Surg. 2015 Jun;14(2):410-6. doi: 10.1007/s12663-014-0638-4. Epub 2014 Jun 28.

Reference Type BACKGROUND
PMID: 26028867 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

F.2-81/2022-GENL/338/JPMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.